fenofibrate has been researched along with Ureteral Obstruction in 1 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Ureteral Obstruction: Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horinouchi, Y | 1 |
| Murashima, Y | 1 |
| Yamada, Y | 1 |
| Yoshioka, S | 1 |
| Fukushima, K | 1 |
| Kure, T | 1 |
| Sasaki, N | 1 |
| Imanishi, M | 1 |
| Fujino, H | 1 |
| Tsuchiya, K | 1 |
| Shinomiya, K | 1 |
| Ikeda, Y | 1 |
1 other study available for fenofibrate and Ureteral Obstruction
| Article | Year |
|---|---|
Pemafibrate inhibited renal dysfunction and fibrosis in a mouse model of adenine-induced chronic kidney disease.
Topics: Animals; Creatinine; Fenofibrate; Fibrosis; Kidney; Mice; PPAR alpha; Renal Insufficiency, Chronic; | 2023 |